| Cover Page | Jan. 29, 2024 |
| Document Information [Line Items] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Jan. 29, 2024 |
| Entity File Number | 001-41719 |
| Entity Registrant Name | 60 DEGREES PHARMACEUTICALS, INC. |
| Entity Central Index Key | 0001946563 |
| Entity Tax Identification Number | 45-2406880 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 1025 Connecticut Avenue NW Suite 1000 |
| Entity Address, City or Town | Washington |
| Entity Address, State or Province | DC |
| Entity Address, Postal Zip Code | 20036 |
| City Area Code | 202 |
| Local Phone Number | 327-5422 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
| Common Stock, par value $0.0001 per share | |
| Document Information [Line Items] | |
| Title of 12(b) Security | Common Stock, par value $0.0001 per share |
| Trading Symbol | SXTP |
| Security Exchange Name | NASDAQ |
| Warrants, each warrant to purchase one share of Common Stock | |
| Document Information [Line Items] | |
| Title of 12(b) Security | Warrants, each warrant to purchase one share of Common Stock |
| Trading Symbol | SXTPW |
| Security Exchange Name | NASDAQ |
